Literature DB >> 18344277

A dosimetric comparison between two intensity-modulated radiotherapy techniques: tomotherapy vs dynamic linear accelerator.

G L Whitelaw1, I Blasiak-Wal, K Cooke, C Usher, N D Macdougall, P N Plowman.   

Abstract

This manuscript describes a direct comparison between radiation treatment plans in terms of dosimetric outcomes created by two different IMRT systems: TomoTherapy HiArt and dynamic linac intensity-modulated radiotherapy (dIMRT). Three patient cases were selected (with disease in different anatomical areas): vertebral metastasis re-treatment, radical prostate therapy and an ethmoid sarcoma re-treatment. Each case presents significant and varying dosimetric difficulties with respect to avoidance of adjacent organs. The patients were each planned and treated at the Cromwell Hospital (London, UK) using the TomoTherapy HiArt system, with planning replicated at St Bartholomew's Hospital (London, UK) using Eclipse Treatment Planning System and a 6EX linac with a 120-leaf multileaf collimator (Varian Medical Systems). For both modalities, all treatment plans conformed to the stringent clinical dose constraints set. For the vertebral body re-treatment, both techniques demonstrated adequate and similar planning target volume (PTV) coverage and sparing of the spinal cord. The critical structure sparing and PTV coverage for the prostate treatment was again similar for both modalities. For re-treatment of the paediatric ethmoid sarcoma, tomotherapy was able to produce slightly better organ sparing whilst producing PTV coverage similar to linac dIMRT. The data presented in this manuscript demonstrate subtle dosimetric differences between the two techniques but no marked advantage with either system. Therefore, other factors may need to be considered when making a decision between tomotherapy and linac dIMRT.

Entities:  

Mesh:

Year:  2008        PMID: 18344277     DOI: 10.1259/bjr/67084583

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  6 in total

1.  Evaluation of normal tissue exposure in patients receiving radiotherapy for pancreatic cancer based on RTOG 0848.

Authors:  Ted C Ling; Jerry M Slater; Rachel Mifflin; Prashanth Nookala; Roger Grove; Anh M Ly; Baldev Patyal; Jerry D Slater; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2015-04

2.  Empirical estimation of beam-on time for prostate cancer patients treated on Tomotherapy.

Authors:  Małgorzata Skórska; Tomasz Piotrowski
Journal:  Rep Pract Oncol Radiother       Date:  2013-02-04

3.  Clinical challenges in the implementation of a tomotherapy service for head and neck cancer patients in a regional UK radiotherapy centre.

Authors:  S Chatterjee; J H Mott; G Smyth; S Dickson; W Dobrowsky; C G Kelly
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

4.  Long-term dosimetric stability of multiple TomoTherapy delivery systems.

Authors:  Jennifer B Smilowitz; David Dunkerley; Patrick M Hill; Poonam Yadav; Mark W Geurts
Journal:  J Appl Clin Med Phys       Date:  2017-05-02       Impact factor: 2.102

5.  Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton and 3D Conformal Radiotherapy (3D-CRT) for Reducing Perioperative Cardiopulmonary Complications in Esophageal Cancer Patients.

Authors:  Ted C Ling; Jerry M Slater; Prashanth Nookala; Rachel Mifflin; Roger Grove; Anh M Ly; Baldev Patyal; Jerry D Slater; Gary Y Yang
Journal:  Cancers (Basel)       Date:  2014-12-05       Impact factor: 6.639

6.  Study of Preoperative Radiotherapy for Sarcomas of the Extremities with Intensity-Modulation, Image-Guidance and Small Safety-margins (PREMISS).

Authors:  Barbara Röper; Christine Heinrich; Victoria Kehl; Hans Rechl; Katja Specht; Klaus Wörtler; Andreas Töpfer; Michael Molls; Severin Kampfer; Rüdiger von Eisenharth-Rothe; Stephanie E Combs
Journal:  BMC Cancer       Date:  2015-11-16       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.